Status:
COMPLETED
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
Lead Sponsor:
National Cancer Institute (NCI)
Collaborating Sponsors:
Mayo Clinic
Conditions:
Endometrial Cancer
Gynecological Cancers
Eligibility:
FEMALE
45-120 years
Brief Summary
Background: \- Endometrial cancer is one of the most common gynecologic cancers. If it is caught at an early stage, it can be treated more easily. Women who have this type of cancer often have a hist...
Detailed Description
Endometrial cancer will account for approximately 47,310 incident cases and 8,010 related deaths in 2012. Most endometrial cancers develop slowly through progression of well characterized precursors, ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Women should meet at least one of the following criteria:
- Abnormal uterine bleeding
- Postmenopausal bleeding
- Thickened endometrial stripe
- Hereditary predisposition to endometrial cancer (e.g. HNPCC)
- Women referred for endometrial biopsy to evaluate suspicion or high risk of endometrial cancer
- EXCLUSION CRITERIA:
- Prior hysterectomy
- Pregnant women (There will be a verbal screen by the clinic nurse and the physician about a potential pregnancy and a pregnancy test may be conducted if there is any doubt)
- Prior pelvic radiation
- Cervical stenosis that renders Tao brush sampling impossible
Exclusion
Key Trial Info
Start Date :
February 11 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 16 2020
Estimated Enrollment :
1932 Patients enrolled
Trial Details
Trial ID
NCT01793545
Start Date
February 11 2013
End Date
November 16 2020
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic, Rochester
Rochester, Minnesota, United States, 55905